Andreas Stallmach

43PUBLICATIONS
97CO-AUTHORS
AllergyPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 02, 2026
International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease.

|May 29, 2026
[Appendectomy as a disease-modifying therapy in ulcerative colitis?]

|Jan 08, 2026
Factors influencing vaccination decisions in patients with inflammatory rheumatic and musculoskeletal disease: a qualitative approach.

Anastasia Suslow, Romy Lauer, Uta Kiltz

|Jan 07, 2026
Choroid plexus alterations in long COVID and their associations with IL-6.

Yuan Cao, Paulo Lizano, Alejandra P Garza

|Dec 09, 2025
Implications of Computerized Tomography Colonography in Fully Intended but Aborted Optical Colonoscopy - a Retrospective Case-Control Study.

Constanze Jakob, Thomas Arens, Annett Borkenhagen

|Jun 20, 2025
CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites.

Johannes Stallhofer, Felix Reichl, Michael Lauseker

Pageof 8

Frequent Collaborators

19 joint publications

Philipp Reuken

8 joint publications

Tony Bruns

7 joint publications

Niels Teich

5 joint publications

Christina Lemhöfer